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INTRODUCTION {#lio2129-sec-0007}
============

The vestibular system is integral to balance control, locomotion, and spatial navigation. Loss of vestibular function can be a debilitating condition that causes imbalance, unsteady vision, and a 12‐fold increased risk of falls and fall‐associated morbidity.[1](#lio2129-bib-0001){ref-type="ref"} Individuals with vestibular loss have difficulty carrying out activities of daily living such as walking, climbing stairs, and driving, and these individuals report increased dependence on others, reduced productivity, and decreased life satisfaction.[2](#lio2129-bib-0002){ref-type="ref"}, [3](#lio2129-bib-0003){ref-type="ref"}, [4](#lio2129-bib-0004){ref-type="ref"}, [5](#lio2129-bib-0005){ref-type="ref"} As with other sensory systems, vestibular function declines with age, and older individuals are disproportionately affected by vestibular loss. Some degree of physiologic vestibular impairment occurs in 50% of older adults age ≥ 60 years,[1](#lio2129-bib-0001){ref-type="ref"} and symptoms of vestibular loss such as imbalance with ambulation or unsteady vision (oscillopsia) are commonly reported by community‐dwelling older adults.[6](#lio2129-bib-0006){ref-type="ref"}, [7](#lio2129-bib-0007){ref-type="ref"}, [8](#lio2129-bib-0008){ref-type="ref"}, [9](#lio2129-bib-0009){ref-type="ref"}, [10](#lio2129-bib-0010){ref-type="ref"} The increased prevalence of vestibular loss in the older population has potentially substantial economic and societal consequences.

Despite the greater prevalence of vestibular loss in older adults and its associated functional limitations, the quality of life (QoL) burden of vestibular loss in this vulnerable population has not been well‐studied. The few studies that have reported QoL outcomes considered the broader symptom of dizziness rather than specifically vestibular physiologic impairment,[7](#lio2129-bib-0007){ref-type="ref"}, [11](#lio2129-bib-0011){ref-type="ref"}, [12](#lio2129-bib-0012){ref-type="ref"}, [13](#lio2129-bib-0013){ref-type="ref"}, [14](#lio2129-bib-0014){ref-type="ref"}, [15](#lio2129-bib-0015){ref-type="ref"} did not have a normative‐age‐matched comparison group available,[11](#lio2129-bib-0011){ref-type="ref"} or were conducted across a broad age range including younger age groups.[7](#lio2129-bib-0007){ref-type="ref"}, [13](#lio2129-bib-0013){ref-type="ref"}, [16](#lio2129-bib-0016){ref-type="ref"}

In this report, we quantify the independent impact of vestibular physiologic loss on overall QoL and identify domains of health including vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain affected by this condition in a sample of older adults with vestibular loss seen in a Neurotology clinic. We compare results in this sample to QoL attainment among age‐matched peers from the general US population. Lastly, we report the individual and societal economic burden of vestibular loss in aging adults using the difference in QoL attainment between the study sample and normative control groups.

MATERIALS AND METHODS {#lio2129-sec-0008}
=====================

Study Design and Study Population {#lio2129-sec-0009}
---------------------------------

Approval for this study was obtained from the Hospital Institutional Review Board. Patients were recruited from the Otology--Neurotology practice within the Department of Otolaryngology--Head and Neck Surgery. Eligible participants were age ≥60 years who presented with dizziness and imbalance, and had evidence of vestibular impairment confirmed by vestibular physiologic testing. A cutoff of ≥60 years of age was used as a defined criteria for an older population.[17](#lio2129-bib-0017){ref-type="ref"} Vestibular testing procedures consisted of standard clinical assessments including head impulse testing (HIT; either qualitative or quantitative using video‐oculography), measurement of cervical vestibular‐evoked myogenic potentials (cVEMP), caloric testing, and/or rotatory chair testing. The patients did not have a specific vestibular diagnosis, such as Menière\'s disease or benign paroxysmal positional vertigo, as this was a study of vestibular loss primarily due to advanced age. Demographic, socioeconomic, and medical history factors were collected for each patient through a medical chart review.

Patients in this study completed a paper‐based QoL survey. The survey included the Health Utilities Index Mark 3 (HUI3) questionnaire, which is a 15‐item, population‐based, validated health utility instrument that measures the respondent\'s general health status and health‐related quality of life along 8 specific domains of function: vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain.[18](#lio2129-bib-0018){ref-type="ref"} It has been used extensively in health economic analyses, including studies of cochlear implantation[19](#lio2129-bib-0019){ref-type="ref"}, [20](#lio2129-bib-0020){ref-type="ref"} and bilateral vestibular deficiency in younger adults.[21](#lio2129-bib-0021){ref-type="ref"} In the present study, each respondent\'s individual domain and overall health utility were calculated using methods prescribed for analysis of HUI3 data,[18](#lio2129-bib-0018){ref-type="ref"} yielding scores ranging from 1 ("perfect health") to 0 ("death") on the individual domains and 1 ("perfect health") to −0.371 (a state "worse than death") on the overall index. The unit for health utility from the HUI3 is the quality‐adjusted life year (QALY).

Normative age‐matched data from the general US population was collected from the 2002--2003 Joint Canada/United States Survey of Health (JCUSH), which is a cross‐sectional random‐digit‐dialed telephone survey conducted in Canada and the United States, administered via a computer‐assisted telephone interview (CATI).[22](#lio2129-bib-0022){ref-type="ref"} The HUI3 is also administered as part of JCUSH. A total of 8,145 people of all ages took part in JCUSH, of which 5,859 participants were US residents. Of these, 1,369 were at least 60 years of age at time of study. Of the eligible adults, 104 (7.6%) participants did not complete the HUI3 questionnaire, resulting in a sample size of 1,265 participants. There were no significant differences between included and excluded participants in the HUI3 survey with respect to gender or race. Included participants, however, were more likely to be younger and single.

Assessment of Comorbidities {#lio2129-sec-0010}
---------------------------

A history of smoking was defined in JCUSH based on smoking greater than 100 cigarettes in one\'s lifetime, and in patients based on a positive smoking history ascertained from the medical record. Hypertension was defined in JCUSH based on responding yes to the question "Have you ever been told by a doctor or other health professional that you have high blood pressure, also called hypertension?" and in patients based on a diagnosis of hypertension in the medical record. Diabetes mellitus was defined in JCUSH based on responding yes to the question "Have you ever been told by a doctor or other health professional that you have diabetes?" and in patients based on a diagnosis of diabetes mellitus in the medical record. Vision loss was defined in JCUSH as a positive response to the question "Do you have problems with vision (whether corrected or uncorrected with glasses or lenses)?" and in patients based on a diagnosis of vision loss from the medical record. Hearing loss was defined in JCUSH based on a positive response to the question "Do you have difficulty hearing (whether corrected or uncorrected with hearing aids) and in patients based on a diagnosis of hearing loss (either self‐reported, or PTA \> 25 dB in the better‐hearing ear) ascertained from the medical record. A history of stroke was defined in JCUSH based on a positive response to the question "What condition or health problem causes you to have difficulty?" with the patient\'s answer as "Stroke problem." JCUSH did not probe directly about a stroke history, but rather a history of stroke was ascertained based on a participant having difficulty in their daily life that they attributed to a history of stroke. As such, 481 individuals in JCUSH were missing data for the stroke variable. We carried out sensitivity analyses including and excluding the stroke variable from analyses to evaluate the impact of these missing data. In general the findings changed very little; therefore we included history of stroke in all analyses.

Discounting and Time Horizon {#lio2129-sec-0011}
----------------------------

Total individual QALYs lost due to vestibular loss were calculated and averaged across all study patients by compounding the yearly adjusted health utility loss associated with vestibular loss across an individual\'s remaining exact age life expectancy stratified by gender.[23](#lio2129-bib-0023){ref-type="ref"} The discount rate is the factor by which individuals preferentially value costs and benefits incurred in the present to those incurred in the future (e.g., one would rather receive \$100 today than \$100 dollars a year from now). A discount rate of 3% was utilized in all base QALY estimates, as it represents the average US government\'s borrowing rate, which has been argued as the most appropriate intra‐generational discounting metric for use in cost‐benefit analyses.[24](#lio2129-bib-0024){ref-type="ref"}, [25](#lio2129-bib-0025){ref-type="ref"} In this case, a 3% discount rate implies that the magnitude of the annual QALY losses associated with vestibular loss (and conversely potential benefits from restoring vestibular function) will decrease with every subsequent year by a factor of 1/1.03 of the prior year\'s value.

Perspective {#lio2129-sec-0012}
-----------

Following collection of individual health‐utility data, a societal perspective analysis was performed to calculate the overall economic burden of vestibular loss using a commonly accepted \$50,000 Willingness‐to‐Pay (WTP) threshold to gain one QALY.[26](#lio2129-bib-0026){ref-type="ref"}

Economic Burden and Sensitivity Analysis {#lio2129-sec-0013}
----------------------------------------

The total economic burden of vestibular loss resulting from the above QALY loss was calculated for the total patient study group and stratified across three age categories, 60--69 years, 70--79 years, and ≥80 years. The study sample\'s QALY losses and associated economic burden was then generalized to the overall susceptible US population 60 years of age and older using an average of literature‐derived prevalence rates of symptomatic vestibular vertigo (from which we expect our study patients were drawn),[6](#lio2129-bib-0006){ref-type="ref"}, [7](#lio2129-bib-0007){ref-type="ref"}, [8](#lio2129-bib-0008){ref-type="ref"}, [10](#lio2129-bib-0010){ref-type="ref"} relative‐prevalence weights by decade of age among US adults,[1](#lio2129-bib-0001){ref-type="ref"} and the size of the US population[27](#lio2129-bib-0027){ref-type="ref"} stratified by above age categories. Base case results were calculated for each age group using a 3% discount rate, a \$50,000 WTP threshold, a weighted symptomatic vestibular loss prevalence of 8%, and an annual QoL decrease equivalent to the vestibular loss coefficient derived from the adjusted generalized linear model of overall HUI. Sensitivity analyses were performed by varying these four parameters.

Statistical analysis {#lio2129-sec-0014}
--------------------

Baseline demographic and medical history factors (Table [1](#lio2129-tbl-0001){ref-type="table-wrap"}) were characterized by mean and standard error for continuous variables and by frequency distributions and percentage of total for categorical variables. Respondents\' overall health states were calculated using the prescribed methodology provided for the HUI3 instrument.[16](#lio2129-bib-0016){ref-type="ref"} Baseline differences in health utilities were explored using a multivariable generalized linear model, allowing for response variables that have both Gaussian and non‐Gaussian distributions. Covariates included demographic (age, gender, race, marital status) and clinical characteristics (history of hypertension, diabetes, stroke, smoking, hearing loss, and vision loss). STATA 13 (Stata Corp, College Station, TX) was used for all statistical analyses.

###### 

Quality of Life Attainment in Patients with Vestibular Loss by Demographic and Medical History Factors

                                                                  Vestibular Loss (n = 27)   General Population (n = 1265)                 
  --------------------------------------------------------------- -------------------------- ------------------------------- ------------- -------------
  Gender                                                                                                                                   
  Male                                                            10 (37.0)                  0.53 (0.35)                     489 (38.7)    0.81 (0.25)
  Female                                                          17 (63.0)                  0.44 (0.32)                     776 (61.3)    0.77 (0.27)
  Age                                                                                                                                      
  60--69 years                                                    6 (22.2)                   0.44 (0.41)                     580 (45.8)    0.82 (0.24)
  70--79 years                                                    12 (44.4)                  0.54 (0.34)                     481 (38.0)    0.79 (0.25)
  ≥80 years                                                       9 (33.3)                   0.40 (0.28)                     204 (16.1)    0.69 (0.30)
  Race                                                                                                                                     
  Non‐Hispanic White                                              21 (80.8)                  0.41 (0.34)                     1000 (82.0)   0.80 (0.25)
  Non‐Hispanic Black                                              4 (15.4)                   0.70 (0.21)                     93 (7.6)      0.68 (0.32)
  Hispanic                                                        NA                         NA                              61 (5.0)      0.72 (0.30)
  Asian                                                           NA                         NA                              21 (1.7)      0.87 (0.21)
  Other                                                           1 (3.8)                    0.82 (0.00)                     4 (3.6)       0.74 (0.28)
  Marital Status                                                                                                                           
  Single                                                          NA                         NA                              58 (4.6)      0.77 (0.26)
  Married                                                         2 (8.0)                    0.10 (0.28)                     606 (47.9)    0.83 (0.24)
  Widowed                                                         17 (68.0)                  0.53 (0.34)                     411 (32.5)    0.73 (0.29)
  Divorced                                                        6 (24.0)                   0.35 (0.23)                     149 (11.8)    0.78 (0.25)
  Unknown                                                         NA                         NA                              41 (3.2)      0.84 (0.21)
  History of Diabetes                                                                                                                      
  Yes                                                             8 (29.6)                   0.54 (0.32)                     177 (15.7)    0.67 (0.30)
  No                                                              19 (70.4)                  0.44 (0.34)                     953 (84.3)    0.80 (0.25)
  History of Hypertension                                                                                                                  
  Yes                                                             21 (77.8)                  0.44 (0.34)                     639 (50.7)    0.76 (0.28)
  No                                                              6 (22.2)                   0.57 (0.31)                     621 (49.3)    0.82 (0.23)
  History of Stroke[b](#lio2129-note-0004){ref-type="fn"}                                                                                  
  Yes                                                             3 (11.1)                   0.29 (0.17)                     26 (3.3)      0.28 (0.27)
  No                                                              24 (88.9)                  0.50 (0.34)                     758 (96.7)    0.72 (0.28)
  History of Smoking                                                                                                                       
  Yes                                                             15 (55.6)                  0.44 (0.38)                     651 (51.8)    0.79 (0.26)
  No                                                              12 (44.4)                  0.51 (0.25)                     606 (48.2)    0.79 (0.26)
  History of Hearing Loss[c](#lio2129-note-0005){ref-type="fn"}                                                                            
  Yes                                                             18 (66.7)                  0.52 (0.27)                     122 (9.6)     0.55 (0.29)
  No                                                              9 (33.3)                   0.38 (0.42)                     1143 (90.4)   0.81 (0.24)
  History of Vision Loss[d](#lio2129-note-0006){ref-type="fn"}                                                                             
  Yes                                                             11 (40.7)                  0.46 (0.33)                     1006 (88.8)   0.77 (0.27)
  No                                                              16 (59.3)                  0.48 (0.34)                     127 (11.2)    0.78 (0.27)

Health Utilities Index measured using Mark III transforms.

481 participants were missing data about a history of stroke, given how the variable was coded, see text for details.

History of hearing loss assessed by average pure‐tone hearing threshold (\>25 dB) in the vestibular loss group and by participant response to presence of self‐reported or diagnosed hearing problems in the Joint Canada/United States Survey of Health

History of vision loss assessed by presence of ophthalmologic comorbidities in the vestibular loss group and by participant response to presence of self‐reported or diagnosed vision problems in the Joint Canada/United States Survey of Health

HUI3, Health Utilities Index Mark III; NA, not applicable; SE, standard error

RESULTS {#lio2129-sec-0015}
=======

Demographic and clinical characteristics of the vestibular loss patient and general population groups are shown in Table [1](#lio2129-tbl-0001){ref-type="table-wrap"}. The mean age and age ranges for the study and control groups was 76.3 (60--87) and 71.4 (60--85) years, respectively. Patients in the study group in general had greater comorbidity relative to the general population, with higher prevalences of diabetes, hypertension, stroke, smoking, and hearing loss. For most demographic and all comorbidity factors, the patient population had a lower HUI3 mean score. All of the patients in the study group had physiologic evidence of vestibular hypofunction that was not attributable to a specific diagnosis other than age. There were 21 (78%) patients with bilateral vestibular loss (BVL) and 6 (22%) patients with unilateral vestibular loss (UVL) in the patient group (Table [2](#lio2129-tbl-0002){ref-type="table-wrap"}).

###### 

Characteristics of Subjects with Vestibular Loss.

  Participant   Age (years)   Gender           Bilateral[a](#lio2129-note-0008){ref-type="fn"}   Basis for Diagnosis[b](#lio2129-note-0009){ref-type="fn"}
  ------------- ------------- ---------------- ------------------------------------------------- -----------------------------------------------------------
  1             60            Male             Yes                                               HIT abnormal AU, absent cVEMP AU
  2             64            Female           Yes                                               HIT abnormal AU, absent cVEMP AS
  3             67            Female           No                                                HIT abnormal AS
  4             67            Male             No                                                HIT abnormal AS
  5             67            Female           Yes                                               HIT abnormal AU, caloric weakness AS
  6             69            Female           Yes                                               Caloric weakness AS, absent cVEMP AU
  7             70            Female           No                                                HIT abnormal AS, absent cVEMP AD
  8             70            Male             Yes                                               Rotatory chair testing abnormal AU
  9             71            Female           Yes                                               Absent cVEMP AU
  10            72            Female           Yes                                               HIT abnormal AU
  11            74            Female           Yes                                               HIT abnormal AU
  12            74            Female           Yes                                               HIT abnormal AU
  13            77            Male             Yes                                               HIT abnormal AU, caloric weakness AS, absent cVEMP AS
  14            77            Male             Yes                                               HIT abnormal AS, caloric weakness AS, absent cVEMP AD
  15            78            Female           Yes                                               HIT abnormal AU, absent cVEMP AS
  16            78            Female           Yes                                               HIT abnormal AU, no caloric response AS, absent cVEMP AU
  17            79            Male             No                                                HIT abnormal AU
  18            79            Male             Yes                                               Caloric weakness AU, absent cVEMP AU
  19            80            Female           Yes                                               HIT abnormal AU
  20            83            Male             No                                                HIT abnormal AS
  21            84            Female           Yes                                               HIT abnormal AU
  22            84            Female           Yes                                               HIT abnormal AU
  23            86            Male             Yes                                               HIT abnormal AU, absent cVEMP AD
  24            87            Female           Yes                                               HIT abnormal AU
  25            87            Female           No                                                HIT abnormal AU, absent cVEMP AU
  26            87            Male             Yes                                               HIT abnormal AU, absent cVEMP AU
  27            87            Female           Yes                                               HIT abnormal AU
  **Overall**   **76**        **63% Female**   **78% Bilateral**                                 

Bilateral vs unilateral vestibular loss.

For unilateral caloric weakness, inter‐aural asymmetry \> 20%, for bilateral caloric weakness, total slow phase velocity \< 20 degrees/second.

AD, right ear; AS, left ear; AU, both ears; cVEMP, cervical vestibular‐evoked myogenic potential; HIT, head impulse testing

There was a 100% response rate for the HUI3 questions among patient respondents. Mean unadjusted HUI3 overall and domain‐specific scores of study sample versus general population controls are shown in Figure [1](#lio2129-fig-0001){ref-type="fig"}. The overall HUI score was 0.47 among patients (on a scale from −0.371 to 1 as described previously) compared to 0.79 among age‐matched general population controls. Statistically significant differences between patient and control groups were observed for overall score (*p* \< 0.001), and for specific domains including vision (*p* \< 0.002), hearing (*p* \< 0.001), speech (*p* \< 0.001), ambulation (*p* \< 0.001), dexterity (*p* \< 0.001), and emotion (*p* \< 0.001) in unadjusted comparisons. Table [3](#lio2129-tbl-0003){ref-type="table-wrap"} reports results of a multivariable generalized linear model analysis of variables associated with overall HUI3 score. After adjusting for gender, age, race, marital status, history of diabetes, hypertension, stroke, smoking, hearing loss, and vision loss, vestibular loss was responsible for a 0.15 decrease in overall health utility (*p* = 0.0105). Covariates significantly associated with a decreased overall HUI score included age ≥80 years (−0.07, *p* = 0.0253), non‐Hispanic Black race (−0.10, *p* = 0.0054), Hispanic race (−0.12, *p* = 0.0087), history of diabetes (−0.08, *p* = 0.0014), stroke (−0.36, *p* \< 0.0001), vision loss (−0.07, *p* = 0.0075), and hearing loss (−0.18, *p* \< 0.0001). A marital status of "married" correlated with a significantly increased overall HUI score (0.12, *p* = 0.0110).

![Mean unadjusted HUI3 domain and overall scores for patients with vestibular loss and the general population](LIO2-3-8-g001){#lio2129-fig-0001}

###### 

Multivariable Adjusted Generalized Linear Model on the Association of Overall HUI3 Score with Vestibular Loss.

                                                       Health Utilities Index Mark III Overall Score[b](#lio2129-note-0012){ref-type="fn"}                                               
  ---------------------------------------------------- ------------------------------------------------------------------------------------- ------------------------------------------- -------------------------------------------
  Vestibular Loss                                      −0.15                                                                                 −0.26, −0.03                                0.0105
  Female                                               −0.01                                                                                 −0.06, 0.04                                 0.7558
  Age                                                                                                                                                                                    
  65--69 years                                         ref[a](#lio2129-note-0011){ref-type="fn"}                                             ref[a](#lio2129-note-0011){ref-type="fn"}   ref[a](#lio2129-note-0011){ref-type="fn"}
  70--79 years                                         −0.01                                                                                 −0.05, 0.04                                 0.8075
  ≥80 years                                            −0.07                                                                                 −0.13, −0.01                                0.0253
  Race                                                                                                                                                                                   
  Non‐Hispanic White                                   ref[a](#lio2129-note-0011){ref-type="fn"}                                             ref[a](#lio2129-note-0011){ref-type="fn"}   ref[a](#lio2129-note-0011){ref-type="fn"}
  Non‐Hispanic Black                                   −0.10                                                                                 −0.17, −0.03                                0.0054
  Hispanic                                             −0.12                                                                                 −0.21, −0.03                                0.0087
  Asian                                                0.13                                                                                  −0.10, 0.37                                 0.2684
  Other                                                −0.03                                                                                 −0.14, 0.08                                 0.5602
  Marital Status                                                                                                                                                                         
  Single                                               ref[a](#lio2129-note-0011){ref-type="fn"}                                             ref[a](#lio2129-note-0011){ref-type="fn"}   ref[a](#lio2129-note-0011){ref-type="fn"}
  Married                                              0.12                                                                                  0.03, 0.22                                  0.0110
  Widowed                                              0.07                                                                                  −0.03, 0.17                                 0.1729
  Divorced                                             0.08                                                                                  −0.02, 0.19                                 0.1276
  Diabetes                                             −0.08                                                                                 −0.13, −0.03                                0.0014
  Hypertension                                         −0.01                                                                                 −0.05, 0.03                                 0.7240
  Stroke                                               −0.36                                                                                 −0.47, −0.25                                \<0.0001
  Smoking                                              −0.02                                                                                 −0.06, 0.03                                 0.4469
  Vision Loss[c](#lio2129-note-0013){ref-type="fn"}    −0.07                                                                                 −0.12, −0.02                                0.0075
  Hearing Loss[d](#lio2129-note-0014){ref-type="fn"}   −0.18                                                                                 −0.24, −0.12                                \<0.0001

Reference group

Health Utilities Index measured using Mark III transforms.

History of vision loss assessed by presence of ophthalmologic comorbidities in the vestibular loss group and by participant response to presence of self‐reported or diagnosed vision problems in the Joint Canada/United States Survey of Health.

History of hearing loss assessed by average pure‐tone hearing threshold (\>25 dB) in the vestibular loss group and by participant response to presence of self‐reported or diagnosed hearing problems in the Joint Canada/United States Survey of Health.

Table [4](#lio2129-tbl-0004){ref-type="table-wrap"} presents results of multivariate generalized linear models on the association of vestibular loss with individual HUI domains, adjusted for the same variables as above. Statistically significant declines in domain‐specific health‐utility due to vestibular loss were observed with respect to vision (−0.11, *p* \< 0.0001), speech (−0.15, *p* \< 0.0001), dexterity (−0.13, *p* \< 0.0001), and emotion (−0.07, *p* = 0.0065). Alternatively, vestibular loss was associated with a significant increase in domain‐specific health‐utility with respect to hearing (0.04, *p* = 0.0440).

###### 

Multivariable Adjusted Generalized Linear Models on the Association of Vestibular Dysfunction with Individual HUI3 Domains.

               Vestibular Dysfunction                  
  ------------ ------------------------ -------------- ----------
  Vision       −0.11                    −0.15, −0.07   \<0.0001
  Hearing      0.04                     0.00, 0.08     0.0440
  Speech       −0.15                    −0.18, −0.11   \<0.0001
  Ambulation   −0.08                    −0.17, 0.01    0.0672
  Dexterity    −0.13                    −0.19, −0.08   \<0.0001
  Emotion      −0.07                    −0.13, −0.02   0.0065
  Cognition    0.01                     −0.06, 0.08    0.8041
  Pain         0.05                     −0.06, 0.17    0.3783

HUI3, Health Utilities Index Mark III.

All models adjusted for age, gender, race, marital status, history of diabetes, hypertension, and stroke.

Lifetime QALY losses for the patient population were then calculated by discounting the adjusted 0.15 decrease in health utility (in QALY units) associated with vestibular loss from the above model across the remaining life‐expectancy of each study participant, at an annual discount rate of 3% (Table [5](#lio2129-tbl-0005){ref-type="table-wrap"}). This resulted in a total of 27.51 QALYs lost across the expected remaining lifetimes of the study population. This total number of QALYs was divided by the number of study patients (N = 27) yielding an average 1.30 lifetime QALYs lost per individual.

###### 

Expected Lifetime HUI Loss Associated with Vestibular Loss in Older Adults.

  Participant   Years to Life Expectancy[a](#lio2129-note-0018){ref-type="fn"}   Expected Lifetime HUI Loss[b](#lio2129-note-0019){ref-type="fn"} (QALYs)
  ------------- ---------------------------------------------------------------- --------------------------------------------------------------------------
  1             21.4                                                             2.26
  2             21.0                                                             2.23
  3             18.6                                                             1.94
  4             18.6                                                             0.69
  5             16.1                                                             1.80
  6             18.6                                                             2.03
  7             16.3                                                             1.82
  8             14.1                                                             1.61
  9             15.6                                                             1.75
  10            14.9                                                             1.68
  11            13.5                                                             1.55
  12            13.5                                                             1.54
  13            10.9                                                             1.63
  14            9.7                                                              1.13
  15            10.8                                                             1.26
  16            10.8                                                             1.26
  17            8.6                                                              1.01
  18            8.6                                                              0.97
  19            10.2                                                             1.19
  20            6.7                                                              0.90
  21            7.4                                                              0.86
  22            7.4                                                              0.86
  23            5.4                                                              0.61
  24            6.0                                                              0.69
  25            5.0                                                              0.42
  26            6.0                                                              0.69
  27            6.0                                                              0.69
  Total         321.8                                                            35.06
  Average       11.9                                                             1.30

QALYS, Quality‐Adjusted Life Years; HUI, Health Utilities Index

Derived using US Social Security Administration\'s Exact Age Actuarial Life Expectancy Tables stratified by gender, <http://www.ssa.gov/oact/STATS/table4c6.html>.

Using an annual HUI loss of 0.15 at a discount rate of 3% across the years to life expectancy

Assuming a \$50,000/QALY WTP, the average lifetime economic burden of vestibular loss per affected older adult stratified into three age categories was \$91,241, \$71,698, and \$38,363 for 60--69 years, 70--79 years, and ≥80 years of age, respectively (Table [6](#lio2129-tbl-0006){ref-type="table-wrap"}). When aggregated across the entire susceptible US population, these estimates resulted in a lifetime societal burden of \$106 billion, \$79 billion, and \$41 billion across each of the above age groups, respectively. When combined across all three age groups, the total lifetime economic burden of vestibular loss per affected older individual was \$64,929, resulting in an aggregate \$227 billion societal burden of vestibular loss in older adults.

###### 

Economic Burden of Vestibular Loss in Older Adults and Sensitivity Analysis

                 Symptomatic Vestibular Loss Prevalence[a](#lio2129-note-0021){ref-type="fn"}   Affected Population[b](#lio2129-note-0022){ref-type="fn"}   Average QALYs Lost[c](#lio2129-note-0023){ref-type="fn"}   Population QALYs Lost[d](#lio2129-note-0024){ref-type="fn"}   \$/QALY[e](#lio2129-note-0025){ref-type="fn"}   Individual Burden[f](#lio2129-note-0026){ref-type="fn"}   Societal Burden (billion)[g](#lio2129-note-0027){ref-type="fn"}
  -------------- ------------------------------------------------------------------------------ ----------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------- ----------------------------------------------- --------------------------------------------------------- -----------------------------------------------------------------
  Base Case                                                                                                                                                                                                                                                                                                                                                                                    
  60--69 years   0.07                                                                           1,164,166                                                   1.82                                                       2,124,388                                                     \$50,000                                        \$91,241                                                  \$106.22
  70--79 years   0.09                                                                           1,105,494                                                   1.43                                                       1,585,227                                                     \$50,000                                        \$71,698                                                  \$79.26
  \>=80 years    0.11                                                                           1,077,104                                                   0.77                                                       826,426                                                       \$50,000                                        \$38,363                                                  \$41.32
  Total          0.08                                                                           3,346,764                                                   1.30                                                       4,346,050                                                     \$50,000                                        \$64,929                                                  \$226.80

                         Base Estimate   Range of Estimate (Lowest to Highest)                     60--69 years (Base \$91,241)   70--79 years (Base \$71,698)   \>=80 years (Base \$38,363)   Overall Individual Burden (Base \$64,929)   Societal Burden (Base \$226.80 billion)
  ---------------------- --------------- --------------------------------------------------------- ------------------------------ ------------------------------ ----------------------------- ------------------------------------------- -----------------------------------------
  Sensitivity Analysis                                                                                                                                                                                                                     
  Variables                                                                                                                                                                                                                                
  Discount rate          3%              0--6                                                      \$72,547‐\$118,375             \$61,571‐\$84,994              \$34,781‐\$42,583             \$55,080‐\$78,275                           \$189.99‐\$277.63
  Annual HUI Loss        0.15            0.10‐0.20                                                 \$65,827‐\$131,654             \$52,382‐\$104,764             \$30,576‐\$61,151             \$48,101‐\$96,202                           \$167.47‐\$334.95
  Average Prevalence     0.08            0.07‐0.10[a](#lio2129-note-0021){ref-type="fn"}           Unchanged                      Unchanged                      Unchanged                     Unchanged                                   \$283.10‐\$404.42
  \$/QALY                \$50,000        \$25,000‐\$75,000[e](#lio2129-note-0025){ref-type="fn"}   \$45,620‐\$136,861             \$35,849‐\$107,546             \$19,182‐\$57,545             \$32,465‐\$97,394                           \$113.40‐\$340.20

Abbreviations: QALY, Quality‐Adjusted Life Year

Using an average of literature‐derived prevalence of vestibular vertigo with relative age‐category weights from Agrawal et al (2009).

Derived using 2013 US Census data stratified by age; [www.census.gov](http://www.census.gov).

Using an annual health‐utility loss of 0.15 at a discount rate of 3% across the years to life expectancy in the vestibular loss study group

Product of discounted average QALYs lost and affected population

Using highly conservative Willingness‐to‐Pay (WTP) thresholds derived from Hirth et al. (2000).

Lifetime Economic Burden of vestibular loss per Affected Individual, product of Population QALYs Lost and \$/QALY divided by Affected Population

Lifetime Societal Burden of vestibular loss, product of Population QALYs Lost and \$/QALY

Sensitivity analyses for the lifetime economic burden of vestibular loss per affected older adult ranged from \$32,465 to \$97,394 and were most sensitive to changes in health utility loss and WTP thresholds (Table [6](#lio2129-tbl-0006){ref-type="table-wrap"}). Altering these parameters yielded a societal lifetime economic burden of vestibular loss ranging from \$113 to \$404 billion.

DISCUSSION {#lio2129-sec-0016}
==========

These analyses offer evidence of a strong association between vestibular loss and poor QoL outcomes in a sample of older adults with symptomatic and idiopathic vestibular loss seen in a Neurotology clinic. Only one study has previously published the QoL impact of vestibular impairment using the HUI3 survey.[21](#lio2129-bib-0021){ref-type="ref"} Although focused on a considerably younger patient population, the authors of that study reported mean HUI3 scores of 0.39 and 0.63 for BVL and UVL respondents, respectively. Given the predominance of BVL patients in our study population, our mean score of 0.47 corroborated these findings. A mean HUI3 score of 0.47 is classified as severe disability by HUI3 criteria[28](#lio2129-bib-0028){ref-type="ref"} and corresponds to a similar level of QoL impairment as present in individuals suffering from Parkinson\'s disease (0.45)[29](#lio2129-bib-0029){ref-type="ref"} or untreated osteoarthritis (0.46).[30](#lio2129-bib-0030){ref-type="ref"} Our study suggests that while vestibular loss may be overlooked as a benign chronic condition, it is associated with a pervasive negative impact on health‐related quality of life in older individuals.

Moreover, our results demonstrate that vestibular loss has a significant and independent impact on QoL after adjusting for a wide array of variables, including cardiovascular risk factors, vision loss, and hearing loss. The 0.15 decrease in mean adjusted HUI3 score associated with vestibular loss is the third largest QoL reduction observed in our study, behind stroke (−0.36) and clinically significant hearing impairment (−0.18). To further contextualize the magnitude of the QoL burden of vestibular loss, this impairment is equivalent to aging 27 years based on an average HUI3 decrease of 0.054 per decade of life.[31](#lio2129-bib-0031){ref-type="ref"}

Individual HUI3 domain scores reveal that the QoL impact of vestibular loss in older adults occurred not only in the expected domains of "vision" and "ambulation," but also in "speech," "dexterity," and "emotion" domains of health. Prior studies support a link between vestibular impairment and emotional health. Vestibular symptoms (specifically dizziness and vertigo) have been associated with social isolation, reduced autonomy, and difficulty performing activities of daily living in older adults, likely contributing to the emotional burden of these symptoms.[7](#lio2129-bib-0007){ref-type="ref"}, [32](#lio2129-bib-0032){ref-type="ref"}, [33](#lio2129-bib-0033){ref-type="ref"} Additionally, a recent epidemiologic study found that individuals with vestibular vertigo had a three‐fold increased odds of depressive symptoms, anxiety, and panic disorder than the general US population in adjusted analyses.[34](#lio2129-bib-0034){ref-type="ref"} An association between vestibular function and dexterity is supported by recent anatomic studies demonstrating vestibular inputs into central motor control centers such as the basal ganglia,[35](#lio2129-bib-0035){ref-type="ref"} and epidemiologic studies showing an association between vestibular function and fine motor tasks.[36](#lio2129-bib-0036){ref-type="ref"} The association between vestibular function and speech is more elusive, and may reflect the general link with motor control, and/or neural pathways that remain to be elucidated.

The overall low QoL attainment among older adults with vestibular loss carries significant individual and societal economic implications. Even without considering the economic consequences of reduced productivity (study participants were assumed to be out of the labor force) or health expenditures to treat their vestibular symptoms, vestibular loss was associated with an average \$64,929 loss in individual welfare over an 11.9 year age life expectancy for our study population. The authors of a recent study also determined an estimated mean annual economic burden of \$13,019 and \$3531 for BVL and UVL patients, respectively.[21](#lio2129-bib-0021){ref-type="ref"} Although the patient population was different as described previously, these approximations support the average \$5,456 annual loss in individual welfare determined in this report. The resultant \$227 billion aggregate economic burden may represent an opportunity to considerably reduce health care costs through timely diagnosis and treatment of vestibular loss.[37](#lio2129-bib-0037){ref-type="ref"}

Several limitations exist in this study, including the small sample size for the study group. The large effect size of the QoL reduction and statistical significance of the results, even after adjusting for a wide array of confounding variables, however, mitigates some of these concerns. Additionally, the use of cross‐sectional data in this analysis precludes causal inference and allows only for the determination of associations between QoL attainment and vestibular loss. Furthermore, relying on patient self‐reporting introduces a source of response bias due to variability in understanding of the questionnaires and the subjective nature of participants\' symptoms. Although estimates of vestibular loss prevalence and incidence have been computed in several recent publications,[6](#lio2129-bib-0006){ref-type="ref"}, [7](#lio2129-bib-0007){ref-type="ref"}, [8](#lio2129-bib-0008){ref-type="ref"}, [10](#lio2129-bib-0010){ref-type="ref"} the absence of large‐scale, high‐quality epidemiological data that are based on objective, specific assessments of vestibular function makes it difficult to determine how well our study population represents the spectrum of health‐related quality of life among older individuals with symptomatic vestibular loss. This study population was also not a random sample, and therefore, the calculated lifetime societal burden of vestibular loss aggregated across the entire US population may not accurately represent the effects of vestibular loss in the general geriatric population. Finally, vestibular function was not measured in JCUSH, and our analyses assumed a zero prevalence, which if anything would have conservatively biased our results. Further limitations of the JCUSH data have been published previously.[38](#lio2129-bib-0038){ref-type="ref"}

CONCLUSION {#lio2129-sec-0017}
==========

Our results demonstrate that age‐related vestibular loss among patients presenting to a Neurotology clinic was associated with a 0.15 reduction in HUI3 score, which corresponds to a loss of 1.30 quality‐adjusted life years. These data suggest that loss of vestibular function in older individuals can confer a significant decrement in quality of life, and is associated with substantial societal cost. Further studies are needed to measure the benefits of vestibular therapy from both the individual and societal perspective.
